Skip to content
10-Q

Quarterly Report

BIOLARGO, INC. BLGO

0001437749-25-027021

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 12, 2025 308.99M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$3.95M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $330K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $3.47M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.55M
Stockholders Equity Q2 2025 · Jun 30, 2025 $8.76M
Stockholders Equity Q2 2025 · Dec 31, 2024 $8.85M
Current Liabilities Q2 2025 · Jun 30, 2025 $4.08M
Current Liabilities Q2 2025 · Dec 31, 2024 $2.65M
Total Liabilities Q2 2025 · Jun 30, 2025 $6.44M
Total Liabilities Q2 2025 · Dec 31, 2024 $4.46M
Current Assets Q2 2025 · Jun 30, 2025 $9.19M
Current Assets Q2 2025 · Dec 31, 2024 $7.14M
Total Assets Q2 2025 · Jun 30, 2025 $12.5M
Total Assets Q2 2025 · Dec 31, 2024 $10.51M
Eps Basic Q2 2025 · Jun 30, 2025 −$0.00
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2024 −$0.00
Eps Basic Q2 2025 · Jun 30, 2024 −$0.00
Sga Expense Q2 2025 · Jun 30, 2025 $2.69M
Sga Expense Q2 2025 · Jun 30, 2025 $5.25M
Sga Expense Q2 2025 · Jun 30, 2024 $2.4M
Sga Expense Q2 2025 · Jun 30, 2024 $4.63M
Rd Expense Q2 2025 · Jun 30, 2025 $535K
Rd Expense Q2 2025 · Jun 30, 2025 $1.32M
Rd Expense Q2 2025 · Jun 30, 2024 $623K
Rd Expense Q2 2025 · Jun 30, 2024 $1.41M
Operating Income Q2 2025 · Jun 30, 2025 −$1.8M
Operating Income Q2 2025 · Jun 30, 2025 −$3.66M
Operating Income Q2 2025 · Jun 30, 2024 −$890K
Operating Income Q2 2025 · Jun 30, 2024 −$1.65M
Gross Profit Q2 2025 · Jun 30, 2025 $1.42M
Gross Profit Q2 2025 · Jun 30, 2025 $2.91M
Gross Profit Q2 2025 · Jun 30, 2024 $2.14M
Gross Profit Q2 2025 · Jun 30, 2024 $4.38M